iRhythm price to free cash flow IRTC
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 103×
- Peer median
- 27.3×
iRhythm's price to free cash flow is 103× as of Oct 23, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 27.3×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 103× | 90.2× | 222× |
| 2025 | 176× | 168× | 354× |
Against its peers
Companies in Medical - Instruments & Supplies nearest iRhythm's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| IRTCiRhythm | 103× |
| ICUIICU Medical | 27.3× |
| NVSTEnvista | 15.3× |
| BMIBadger Meter | 29.2× |
| VNTVontier | 12.1× |
| WRBYWarby Parker | 147× |
| ATRCAtriCure | 56.5× |
| HAEHaemonetics | 18.5× |
| MMSIMerit Medical Systems | 27.4× |
| UFPTUFP Technologies | n/m |
| MSAMSA Safety | 19.8× |
| Peer median | 27.3× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on iRhythm
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.